Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.

被引：1
|
作者：
Zimmer, Lisa
Eigentler, Thomas K.
Vaubel, Julia-Marianne
Mohr, Peter
Jradi, Zeinab
Kiecker, Felix
Utikal, Jochen
Berking, Carola
Kaempgen, Eckhart
Hauschild, Axel
Dippel, Edgar
Rompel, Rainer
Fluck, Michael
Stadler, Rudolf
Herbst, Rudolf
Terheyden, Patrick
Garbe, Claus
Loquai, Carmen
Schadendorf, Dirk
机构：
[1] Univ Duisburg Essen, Univ Hosp, Dept Dermatol, Essen, Germany
[2] Univ Tubingen, Dept Dermatol, Tubingen, Germany
[3] Elbekliniken, Dermatol Zentrum, Buxtehude, Germany
[4] Charite Campus Mitte, Univ Dept Dermatol, Berlin, Germany
[5] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany
[6] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Mannheim, Germany
[7] Univ Munich LMU, Dept Dermatol, Munich, Germany
[8] Univ Hosp, Dept Dermatol, Erlangen, Germany
[9] Univ Hosp Schleswig Holstein, Kiel, Germany
[10] Dept Dermatol, Ludwigshafen, Germany
[11] Dept Dermatol, Kassel, Germany
[12] Dept Dermatol, Munster, Germany
[13] Dept Dermatol, Minden, Germany
[14] Dept Dermatol, Erfurt, Germany
[15] Univ Hosp UKSH, Dept Dermatol, Lubeck, Germany
[16] Univ Tubingen Hosp, Dept Dermatol, Tubingen, Germany
[17] Univ Dept Dermatol, Mainz, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.9031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9031
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Safety and Efficacy of Apatinib Monotherapy for Unresectable, Metastatic Esophageal Cancer: A Single-Arm, Open-Label, Phase II Study
    Li Yanwei
    Feng, He
    Ren, Peng
    Yue, Jie
    Zhang, Wencheng
    Tang, Peng
    Shang, Xiaobin
    Pang, Qingsong
    Liu, Dongying
    Chen, Chuangui
    Pan, Zhanyu
    Tao, Yu Zhen
    ONCOLOGIST, 2020, 25 (10): : E1464 - E1472
  • [42] Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study
    Zager, Jonathan S.
    Orloff, Marlana
    Ferrucci, Pier Francesco
    Choi, Junsung
    Eschelman, David J.
    Glazer, Evan S.
    Ejaz, Aslam
    Howard, J. Harrison
    Richtig, Erika
    Ochsenreither, Sebastian
    Reddy, Sunil A.
    Lowe, Michael C.
    Beasley, Georgia M.
    Gesierich, Anja
    Bender, Armin
    Gschnell, Martin
    Dummer, Reinhard
    Rivoire, Michel
    Arance, Ana
    Fenwick, Stephen William
    Sacco, Joseph J.
    Haferkamp, Sebastian
    Weishaupt, Carsten
    John, Johnny
    Wheater, Matthew
    Ottensmeier, Christian H.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 5340 - 5351
  • [43] Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
    Ali A. Mokdad
    Hao Zhu
    Muhammad S. Beg
    Yull Arriaga
    Jonathan E. Dowell
    Amit G. Singal
    Adam C. Yopp
    Targeted Oncology, 2019, 14 : 541 - 550
  • [44] Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial
    Mokdad, Ali A.
    Zhu, Hao
    Beg, Muhammad S.
    Arriaga, Yull
    Dowell, Jonathan E.
    Singal, Amit G.
    Yopp, Adam C.
    TARGETED ONCOLOGY, 2019, 14 (05) : 541 - 550
  • [45] Efficacy and safety of endostatin in combination with chemotherapy in small cell lung cancer: a phase 2 single-arm multicenter open-label trial
    Zhao, Yi
    Zhang, Xu
    Jin, Chenxing
    Yu, Xiaomin
    Zhang, Min
    Cao, Yang
    Li, Ying
    Wang, Aman
    Shan, Xiu
    Zhang, Jia
    Wang, Juhong
    Yin, Liu
    Tan, Xiaoxin
    Liu, Jiwei
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (03) : 3277 - 3285
  • [46] Efficacy and safety of DCVAC/LuCa with chemotherapy for patients with stage IV NSCLC: A prospective, open-label, single-arm, phase II study
    Ling, X.
    Xu, J.
    Zhong, R.
    Zhong, H.
    Han, B.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S752 - S753
  • [47] A PROSPECTIVE, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE EFFICACY, SAFETY AND ACCEPTABILITY OF PERICOITAL ORAL CONTRACEPTION WITH LEVONORGESTREL
    Lendvay, A.
    Taylor, D.
    Halpern, V
    Bahamondes, L.
    Fine, P.
    Guide, S.
    Raymond, E.
    CONTRACEPTION, 2012, 86 (03) : 313 - 313
  • [48] Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
    Lan, Chunyan
    Shen, Jingxian
    Wang, Yin
    Li, Jundong
    Liu, Zhimin
    He, Mian
    Cao, Xinping
    Ling, Jiayu
    Huang, Jiaming
    Zheng, Min
    Zou, Guorong
    Yan, Haowen
    Liu, Qing
    Yang, Fan
    Wei, Wei
    Deng, Yanhong
    Xiong, Ying
    Huang, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (34)
  • [49] TORIPALIMAB PLUS CHEMORADIOTHERAPY IN PATIENTS WITH RECURRENT OR METASTATIC CERVICAL CANCER: A MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE II TRIAL
    Xu, Xiaoting
    Huan, Jian
    Miao, Hui
    Wang, Hao
    Wang, Yue
    Zhu, Hongyu
    Jiang, Jun
    Zhou, Juying
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A384 - A384
  • [50] Camrelizumab plus apatinib in patients with advanced cervical cancer: A multicenter, open-label, single-arm, phase II trial.
    Lan, Chunyan
    Huang, Xin
    Shen, Jing-Xian
    Wang, Yin
    Xiong, Ying
    Li, Jundong
    Cao, Xinping
    Deng, Yanhong
    He, Mian
    Zou, Guorong
    Wang, Xiaodi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345